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ABSTRACT
Background: Previous studies have suggested the quorum sensing signal AI-2 as a potential target
to prevent the biofilm formation by Streptococcus mutans, a pathogen involved in tooth decay.
Objective: To obtain inhibition of biofilm formation by S. mutans by extracts obtained from
the marine bacterium Tenacibaculum sp. 20J interfering with the AI-2 quorum sensing system.
Design: The AI-2 inhibitory activity was tested with the biosensors Vibrio harveyi BB170 and
JMH597. S. mutans ATCC25175 biofilm formation was monitored using impedance real-time
measurements with the xCELLigence system®, confocal laser microscopy, and the crystal
violet quantification method.
Results: The addition of the cell extract from Tenacibaculum sp. 20J reduced biofilm formation in
S. mutans ATCC25175 by 40–50% compared to the control without significantly affecting growth.
A decrease of almost 40% was also observed in S. oralisDSM20627 and S. dentisani 7747 biofilms.
Conclusions: The ability of Tenacibaculum sp. 20J to interfere with AI-2 and inhibit biofilm
formation in S. mutans was demonstrated. The results indicate that the inhibition of quorum
sensing processes may constitute a suitable strategy for inhibiting dental plaque formation,
although additional experiments using mixed biofilm models would be required.
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Biofilms are complex microbial communities which
usually have a key role in virulence and antibiotic resis-
tance in pathogenic bacteria [1,2]. In numerous bacter-
ial species, biofilm formation and maturation are
regulated by quorum sensing (QS), a chemical commu-
nication system mediated by extracellular signals that
are thought to enable bacteria to assess population size
and coordinate virulence factor expression [3].
Therefore, the inhibition of QS, a process known as
quorum quenching (QQ), constitutes an interesting
alternative for controlling pathogenic bacterial beha-
viours [4]. Oral biofilms comprise about 500–1,000
species, almost half of them still uncultured [5].
Among them, Streptococcus species are the initial colo-
nizers of clean teeth surfaces and the main components
of early dental plaque. Although Streptococcus mutans
was considered one of the major cariogenic bacteria in
humans in the past [6,7], recent DNA- and RNA-based
studies from carious lesions indicate that this bacterium
represents only a small fraction of the bacterial com-
munity present in these lesions [8]. Biofilm formation
by S. mutans is regulated by two QS systems, although
the hierarchy of their organization is unknown. The QS
system typical of streptococci is regulated by a peptide
pheromone signal called competence stimulating pep-
tide (CSP) [9], which is species-specific and detected by
a histidine-kinase [10]. The inactivation of any of the
genes related to the CSP QS system results in the altera-
tion of biofilm architecture [11]. The other QS signal
related to biofilm formation in S. mutans is AI-2
[7,12,13], which has been proposed as a universal sig-
nalling molecule due to its wide distribution among
prokaryotes [14,15], including important oral patho-
gens [16]. The mutation of the gene of luxS which
codifies the enzyme required for AI-2 production
affects biofilm formation in S. mutans [12,17]. The QS
signal AI-2 seems to be relevant also in other oral
pathogens such as Porphyromonas gingivalis,
Aggregatibacteractinomycetencomitans Y4, Treponema
denticola, and Tannerella forsythia [7,18], which indi-
cates complex signalling networks in the oral biofilm.
According to the hypothesis proposed by Kolenbrander
et al. [19], high levels of AI-2 would accelerate the
growth of pathogens while reducing growth of com-
mensal bacteria, contributing to subgingival plaque for-
mation and maturation and leading to periodontal
diseases. However, LuxS is also a central metabolic
enzyme which plays a crucial role in methionine meta-
bolism [20] and participates in protein, RNA, and DNA
synthesis [17], and therefore, the effects observed when
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its gene is mutated have to be interpreted carefully.
Furanones, which are known to inhibit communication
based on acyl homoserine lactone (AHL) and AI-2
signals [21], have been reported to affect biofilm for-
mation in S. mutans. A previous study indicated that
the biofilm inhibition observed in S. mutans supple-
mented with the furanone C52 is linked with the inter-
ference with AI-2-controlled processes [22]. However,
another study reported the inhibition of biofilm forma-
tion in S. mutans by the synthetic furanone C30
through an unknown mechanism not dependent of
QS-signal AI-2, since the luxSmutant was also affected
[23]. In S. pneumoniae, the use of the natural com-
pound Sinefungin, which interferes with AI-2 synthesis,
also caused the alteration of the biofilm structure and a
concentration-dependent inhibition in biofilm forma-
tion [24].
Preliminary observations of anti-biofilm activity
by Tenacibaculum sp. 20J against several Gram-
positive and marine bacteria prompted us to
study the capacity of cell extracts from 20J to
interfere with communication mediated by the QS
signal AI-2 and biofilm formation in the oral
pathogen S. mutans. Surface-associated growth by
S. mutans was monitored in real-time using the
xCELLigence® technology that measures total bio-
film biomass by combining both cellular growth
and matrix production [25–28]. Moreover, confo-
cal laser scanning microscopy (CLSM) as well as
crystal violet biofilm staining were used to confirm
xCELLigence® results.
Materials and methods
Bacterial strains and growth conditions
The Gram-positive biofilm forming bacteria S.
mutans ATCC25175, S. oralis DSM20627, and S.
dentisani 7747 were routinely cultured in brain
heart infusion (BHI) broth or on BHI agar supple-
mented with 0.1% sucrose at 37°C. Biofilm formation
by S. mutans was also assessed in BHI supplemented
with both sucrose and glucose at 0.1% and 0.2%. The
strain Tenacibaculum sp.20J CECT7426, isolated in
our laboratory from a marine sample [29], and T.
maritimum NCIMB2154T were routinely cultured at
22°C on Marine Agar/Broth pH 7.0 (MA/MB, Difco).
The strains used for the AI-2 bioassay, Vibrio
harveyi BB170 (HAI-1 negative; AI-2 positive; CAI-
1 positive), V. harveyi JMH597 (HAI-1 negative; AI-2
positive; CAI-1 negative) [30], and V. harveyi JAF548,
in which bioluminescence is not under the control of
QS systems due to the permanent activation of the
QS-dependent bioluminescence repressor LuxO
[31,32], were cultured in LB supplemented with 30
μg ml−1 of the antibiotic kanamycin (LB+Km) and in
autoinducer bioassay medium (AB) [33].
Cell extracts preparation
Purified cell extracts (PCEs) were obtained from
50 ml stationary-phase MB cultures of
Tenacibaculum sp. strain 20J and T. maritimum
NCIMB2154T. The cultures were centrifuged for
10 min at 5000 × g in order to separate the biomass
from the culture media. The pellet was washed with
15 ml of phosphate buffered saline (PBS) pH 6.5,
resuspended in 1.5 ml of the same buffer, sonicated
for 5 min in ice, and centrifuged at 16,000 × g for
30 min at 4°C. The PCEs obtained in this way were
filtered through 0.22 μm and stored at 4°C [34]. Total
protein concentration in the PCEs was estimated by
Lowry’s method [35]. For the PCE of strain 20J, one
aliquot was fractioned using Centricon® Centrifugal
Filter Devices (Millipore Corporation, Bedford, MA)
of 100 kDa (YM-100), 50 kDa (YM-50), and 10 kDa
(YM-10). Filters were pre-washed with NaOH 0.1 N
and deionized water. Aliquots of PCEs were also
ultracentrifuged (20 min 300,000 g) or dialysed
using D-tubeTM Dyalizer Mega (EMD Millipore
Corp. Billerica, MA). The PCE (500 μl) was also
extracted twice with an equal volume of ethyl acetate
(EA-PCE 20J). For obtaining the methanolic cell
extract (MCE), the biomass from a 50 ml culture of
Tenacibaculum sp. 20J was resuspended in methanol
(1.5 ml) and treated in the same way as the PCE.
After centrifugation, an aliquot of the MCE was
further extracted twice with an equal volume of
dichloromethane (DM-MCE 20J). Solvents were eva-
porated to dryness in a rotary evaporator system at
40°C and resuspended in PBS pH 6.5.
The PCE of Tenacibaculum sp. 20J was also treated
with proteinase K (100 μg ml−1; Sigma-Aldrich, MO)
at 30°C for 1 h [36]. Thermal stability of the bioactive
compound was tested by incubating the PCE of
Tenacibaculum sp. 20J at 100°C for 10 min [36].
The residual anti-biofilm activity was measured by
using the xCELLigence® System RTCA (ACEA,
Biosciences Inc., CA).
Bioluminescence assay
V. harveyi BB170 (HAI-1 negative; AI-2 positive; CAI-
1 positive), V. harveyi JMH597 (HAI-1 negative; AI-2
positive; CAI-1 negative), and the QS-independent
bioluminescent strain V. harveyi JAF548 were used as
biosensor strains [30–32]. They were grown overnight
in MB at 30°C with shaking. Aliquots of these over-
night cultures were diluted 1:5,000 into fresh AB med-
ium (modified from [30]). In each well of a 96-well
black microtiter plate, 180 µl of V. harveyi dilution and
20 µl of tested compounds were added. Photographs
were taken every hour using the Gel DocTM XR+
system Bio Rad equipment. Experiments were per-
formed in triplicate. The effect of the cell extracts on
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growth of the biosensor strains was monitored mea-
suring the optical density at 600 nm under same con-
ditions as the bioluminescence assay.
Biofilm measurement and analysis
The biofilm quantification was done using the
xCELLigence® System RTCA (ACEA, Biosciences
Inc.) [25–28], in which the increase in the cell adher-
ence on the electrodes causes an increase in the
electrode impedance, which is expressed into a
dimensionless parameter called cell index. E-plates
16 or E-plate 96 (ACEA, Biosciences Inc.) were
inoculated with 180 μl of a 24-h culture of S. mutans
in BHI broth supplemented with 0.1% sucrose
(OD600 adjusted to 0.05) and 20 μl of extracts or
inhibitors. Furanone C30 (0.02 µg ml−1, Sigma-
Aldrich) and the AHL-lactonase Aii20J (20 µg ml−1
[36]) were also tested. Twenty microlitres of PBS pH
6.5 were added to the control wells. The system was
incubated at 37°C for 24 h.
Biofilms of S. mutans were allowed to form on
glass coverslips (18 × 18 mm) using 12-well cell-
culture plates containing 3 mL of BHI broth supple-
mented with 0.1% sucrose (modified from [37]).
After incubation, the supernatant was removed,
wells were rinsed with PBS to remove the planktonic
cells, and the biofilms were stained with either crys-
tal violet or with Syto9 (Thermofisher Scientific) for
CLSM observation. For crystal violet quantification
[modified from [38]], ethanol was added for the
fixation of the biofilms, and after 15 min the super-
natant was removed again. Then, 0.1% crystal violet
(Gram-Hucker, Panreac) solution was added to all
wells, and after 20 min, the excess of dye was
removed washing several times. Bound crystal violet
was released by adding 33% acetic acid. The absor-
bance was measured at 590 nm. The results are
expressed in terms of percentage of biofilm formed
in the presence of extracts in comparison with
untreated wells. All experiments were performed in
triplicate.
Microscopic observation was performed using a
Leica TSC SP2 laser scanning spectral confocal
microscope (Leica Microsystem Heidelberg GmbH,
Mannheim, Germany) with an HCX PL APO 63x/
1.3 Gly. Eight randomly selected fields of each sample
were evaluated. The optical sections were scanned in
1-µm sections from the surface of the biofilm to its
base, measuring the maximum thickness of the field
and subsequently the mean thickness of the biofilm of
the corresponding sample. The quantification of the
percentage of coverage surface (µm2) was obtained
comparing the total surface of the field with the
bacterial biofilm. A Nikon Eclipse E400 microscope
equipped with a Leica MC170 HD camera was used
to image the biofilms stained with crystal violet.
Bacterial growth inhibition
The effect of the cell extracts (100 μg ml−1) and fur-
anone (0.02 μg ml−1) on planktonic growth was inves-
tigated by comparing bacterial growth measured at
600 nm with control cultures after 24 h of incubation.
Cultures were mixed vigorously with a pipette in order
to detach the bacteria. BHI medium supplemented
with 0.1% sucrose and the inoculum of S. mutans with-
out PCE were used as controls. All experiments were
performed in triplicate. Antimicrobial activity of the
cell extracts was also assayed by the disc diffusion test
which was performed on BHI agar. Sterile discs
(Liofilchem®) with a diameter 6 mm were loaded with
20 µl of the cell extracts and the discs placed over plates
inoculated with S. mutans. Plates were then incubated
at 37°C for 24 h and checked for the presence of
inhibitory halos.
Ahl-degradation activity bioassay
The AHL degradation activity of the different extracts
was tested by incubating 500 μl of each extract with
N-hexanoyl-L-homoserine lactone (C6-HSL) 10 μM
for 24 h at 22°C 200 rpm and the remaining AHL was
detected using the biosensor strain Chromobacterium
violaceum CV026 [39,40]. After 24 h of degradation,
100 μl of the mixture were placed in wells made on an
LB plate overlaid with a 1/100 dilution of an over-
night culture of C. violaceum CV026 in soft LB (8%
agar). The plates were incubated for 24 h at 30°C and
the production of violacein was observed. As control,
wells were filled with 100 μl of sterile PBS plus C6-
HSL treated as samples.
Statistical analyses
The student t-test was performed to determine the
statistical significance of the differences in cell index
and bacterial growth by S. mutans between the con-
trol and the treated wells. Significant differences were
determined at P < 0.05.
Results
Cell extracts of Tenacibaculum sp. 20J interfere
with AI-2 signalling
To assess the interference with AI-2-mediated com-
munication, a cell extract from Tenacibaculum sp. 20J
was obtained and tested with the reporter strains V.
harveyi BB170, in which bioluminescence is under
the control of the AI-2 and CAI-1 QS systems, and
V. harveyi JMH597 that only senses the AI-2 signal
[30]. To exclude that 20J-PCE affects biolumines-
cence in V. harveyi through factors nondependent
on QS, the mutant V. harveyi JAF548 [31] in which
bioluminescence is expressed independently of QS
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control was used. Moreover, the Furanone C30,
which was suggested to prevent biofilm formation
in S. mutans previously [22,23], and extracts obtained
from the closely related species T. maritimum
NCBI2154T, a strain with no AHL-lactonase activity
[36], were also tested. Results showed that after 8 h,
the 20J extract completely eliminates light production
by the reporters BB170 and JMH597 compared to
control wells (Figure 1(a)). This delay was not caused
by a delay in growth since the growth curves of the
cultures were identical (data not shown). As expected,
the AHL-lactonase Aii20J, that is present in the cell
extract, had no effect on the luminescence produced
by the reporter BB170. Surprisingly, the addition of
the lactonase accelerated the production of biolumi-
nescence in V. harveyi JMH597 (Figure 1(a)). Neither
the Furanone C30 nor the extracts of T. maritimum
NCBI2154T showed bioluminescence inhibitory
activity on BB170 at the concentrations tested. Since
the addition of 20J extracts did not cause any change
in the production of bioluminescence in the reporter
JAF548, these results suggest the presence of an AI-2
specific inhibitory activity in Tenacibaculum sp. 20J.
The inhibition is not present in the methanolic bio-
mass extract (MCE) of the same species (Figure 1(b)).
Tenacibaculum sp. 20J extracts affect biofilm
formation in streptococcus mutans
In order to study whether the AI-2 inhibitory
activity found in Tenacibaculum sp. 20J extracts
could prevent biofilm formation in S. mutans,
extracts of strain 20J and T. maritimum were
added to cultures of the pathogen and biofilm
formation was assessed using the xCELLigence®
system. A reduction of 50% in the cell index,
the parameter that indicates biofilm formation,
was observed when 20J extract was added to S.
mutans cultures (Figure 2). On the other hand,
although some reduction of cell index was
recorded in cultures supplemented with T. mar-
itimum extracts, this effect was not significant
(P > 0.05) (Figure 2). Furanone C30 did not
cause any reduction in attachment by S. mutans
at the concentration tested (0.02 μg ml−1) as
measured with the xCELLigence® system
(Figure 2). As expected, the AHL-lactonase
Aii20J did not display anti-biofilm activity against
S. mutans. No effect on Staphylococcus aureus
biofilm formation could be observed in treated
cultures, indicating the presence of a specific bio-
film inhibitory activity against S. mutants in 20J
extracts (data not shown).
Optical densities of shaken cultures of S. mutans
were measured to evaluate whether the reduction in
biofilm formation in cultures supplemented with
20J extracts was derived from growth inhibition.
The addition of 20J extracts in S. mutans cultures
showed a biofilm inhibition of 50% in the cell
index (Figure 3(a)), but it had no significant effect
(P > 0.05) on bacterial growth (Figure 3(b)). To
further verify that the inhibitory activity on biofilm
formation does not result from reducing S. mutans
growth, disc diffusion assays were performed with
20J extracts. As a result, no growth inhibition halos
around the discs could be observed (data not
shown) confirming the absence of growth inhibi-
tory activity against S. mutans in the cell extract of
strain 20J.
The biofilm inhibition is not dependent of the
culture media
The culture media BHI was supplemented with two
concentrations of sucrose and glucose (0.1% and
0.2%). Biofilm formation without sugar supplemen-
tation was too low to be reliably detected by the
xCELLigence® system (cell index below 0.05). The
increase in the concentration of both sugars
Figure 1. Effect of QS inhibitors and extracts on biolumines-
cence production by different V. harveyi reporter strains in
96-well cell culture plates. (A) Bioluminescence assays using
V. harveyi BB170 (AHL−, AI2+, CAI+) and V. harveyi JMH597
(AHL−, AI2+, CAI−) with furanone (0.02 µg ml−1), the AHL-
lactonase Aii20J (20 μg ml−1), and the purified cell extracts
from Tenacibaculum sp. 20J (PCE20J) and T. maritimum
(PCETm) (100 μg ml−1). (B) Effect of purified cell extract
(PCE) and methanolic cell extract on bioluminescence pro-
duction by V. harvery BB170, JMH597, and the QS indepen-
dent strain JAF548. Assays were carried out in triplicate. Only
one well is shown for each condition.
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enhanced the adhesion of S. mutans cells, with the
highest cell index being achieved with sucrose 0.2%
(Figure 4). The 20J extract inhibited biofilm
formation in all conditions, with a reduction of
50% of cell index in both sucrose concentrations
and with 0.2% glucose (Figure 4).
Figure 2. Biofilm formation by Streptococcus mutans as measured by xCELLigence® system (■). The effect of purified cell extracts
from Tenacibaculum sp. 20J (Δ), T. maritimum NCIMB2154T (◊) (100 μg ml−1); furanone C30 (○)(0.02 μg ml−1) and the AHL
lactonase Aii20J (˟) (20 μg ml−1) were tested (n = 3).
Figure 3. Effect of cell extracts of Tenacibaculum sp. 20J, T. maritimum (100 μg ml−1) and furanone (0.02 μg ml−1) on biofilm
formation (A) and cell growth (B). Data were measured as cell index (biofilm growth) and OD600 (cell growth) of S. mutans in
comparison to control cultures (100%). Experiments were performed in triplicate.
Figure 4. Effect of the cell extract of Tenacibaculum sp. 20J (100 μg ml−1) on S. mutans cultures inoculated with different sucrose
(0.1% and 0.2%) and glucose (0.1% and 0.2%) concentrations. Data were measured as cell index (biofilm growth) of S. mutans in
comparison to control cultures (100%). Experiments were performed in triplicate.
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Validation of xCELLigence® system results
To validate the biofilm formation results obtained with
the xCELLigence® system, biofilm formation by S.
mutans cultures supplemented with the 20J extract
was studied using epifluorescence and CLSM as well
as crystal violet staining assays. The CLSM observation
showed lower coverage and smaller microcolonies in
20J extract-treated cultures of S. mutans confirming the
data obtained with the xCELLigence® system. The addi-
tion of the AHL-QQ enzyme Aii20J did not cause sig-
nificant changes in the structure of the biofilm (data not
shown). An average reduction of more than 50% in S.
mutans biofilm formation could also be recorded in the
culture supplemented with 20J extract used for CLSM
analysis, although estimation of the surface coverage
using this technique is difficult due to the non-uniform
surface coverage (Figure 5). A significant decrease in the
biofilm thickness was also observed in the plates
(51.38%). The observation of slides stained with crystal
violet also revealed important differences in the area
coverage and the shape of the cell aggregates between
control and 20J-treated biofilms cultured under stan-
dard conditions but the quantification showed no dif-
ferences in biofilm formation (data not shown).
However, a decrease of 25% could be observed in S.
mutans supplemented with PCE20J using the crystal
violet staining assay (Figure 6) when the biofilm forma-
tion was promoted by changing the culture media twice
a day.
Biofilm formation is also affected in other oral
Streptococcus species
In order to know whether the activity of PCE20J
observed in S. mutans is specific, the anti-biofilm
properties of the cell extract were also tested in
other oral streptococci. Biofilm formation in S. oralis
and S. dentisani was too low to be accurately mea-
sured with the xCELLigence® system. The treatment
with PCE20J caused a decrease of almost 40% in S.
oralis DSM20627 and S. dentisani 7747 (Figure 6).
Characterization of the bioactive component of
purified cell extract from Tenacibaculum sp. 20J
To perform a preliminary characterization of the
anti-biofilm compound(s) present in the biomass
of strain 20J, different 20J extracts were obtained
using methanol, ethyl-acetate, and dichloromethane
and tested for anti-biofilm activity against S.
mutans. No effect on biofilm formation or bacterial
growth was recorded for any of the extracts
obtained with organic solvents, suggesting that a
polar molecule is responsible for the anti-biofilm
activity (Figure 7). Moreover, 20J extract fractions
with molecular weights below 100 kDa showed no
effect on S. mutans attachment (Figure 8(a)), hence
either a large molecule should be responsible for the
inhibition of biofilm formation in this bacterium or
the activity is membrane-bound. To confirm these
results, extracts of 20J were either submitted to
ultracentrifugation (20 min at 300,000 g) to remove
large-size particles or dialyzed to remove molecules
smaller than 8 kDa from the extracts. The anti-
biofilm activity in dialyzed extracts was similar to
that of whole 20J extracts, confirming the high
molecular weight of the bioactive compound
(Figure 7(a)). While retaining the anti-biofilm activ-
ity, the dialyzed extract had no growth-inhibitory
activity (Figure 7(b)). Interestingly, a significant loss
of anti-biofilm activity was recorded in superna-
tants from ultracentrifuged extracts (P < 0.05), sug-
gesting that the bioactive compound could be
membrane-bound. The same extracts were assayed
against the AHL C6-HSL in order to verify the
dialysis and ultracentrifugation steps. Expectedly,
due to the soluble nature of the AHL-lactonase
enzyme present in 20J, dialyzed and ultracentri-
fuged extracts retained the AHL degradation activ-
ity. A 20J extract was then heat-inactivated at 100°C
for 10 min or subjected to a proteinase K digestion
at 30°C for 1 h. None of the treatments could
eliminate the anti-biofilm activity present in the
extract (Figure 8(b)), suggesting that either a com-
pound of non-protein nature or a highly resistant
enzyme could be responsible for the anti-biofilm
activity.
Figure 5. Confocal microscope observation (63 ×) of the
effect of the addition of the cell extract if strain 20J
(PCE20J) on biofilm formation by S. mutans. The highest
and the lowest covered surface fields among the eight fields
analysed per sample are shown. A reduction of at least 50%
of covered surface is observed in the presence of PCE20J.
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Discussion
Tenacibaculum sp. 20J was selected as a candidate with
possible anti-AI-2 activity due to preliminary observa-
tions of anti-biofilm activity in Gram-positive and mar-
ine biofilm-forming bacteria not sensitive to the action
of the AHL-QQ enzyme Aii20J. The results indicated
that the aqueous PCE of Tenacibaculum sp. 20J is able
to interfere specifically with the QS system AI-2, in a
manner that is independent of the AHL-degradation
capacity. The concentration of AI-2 in the culture
media of V. harveyi can achieve up to 22.4 μM after
6.5 h of culture [41], therefore the delay in biolumines-
cence production observed in the first 10 h of growth of
cultures supplemented with Tenacibaculum sp. 20J
extracts without affecting growth kinetics strongly sug-
gests the presence of AI-2-inhibitory activity in strain
20J extracts. Importantly, 20J extracts did not affect
bioluminescence in V. harveyi JAF548, in which biolu-
minescence is independent of the QS circuits [31],
indicating that bioluminescence production was not
influenced by unspecific environmental factors [42,43].
Given that biofilm formation is regulated by AI-2
signalling in S. mutans [7,12,13], we decided to assess
whether 20J extracts could interfere with biofilm for-
mation of this early dental plaque colonizer. Indeed,
the biofilm-inhibitory activity recorded in extracts of
strain 20J suggested that it could be derived from the
interference with the AI-2 QS system in S. mutans.
The reduction of S. mutans biofilm formation is not
resulting from growth inhibition since dialyzed
extracts retained the anti-biofilm activity and
favoured planktonic growth in comparison to
untreated and control cultures. A preliminary analy-
sis, including dialysis and ultracentrifugation, indi-
cated that the active compound in 20J extracts is a
large, possibly membrane-associated molecule.
Despite the bioactive molecule is not affected by
heat treatment and proteinase K digestion, it cannot
Figure 6. Biofilm formation quantified by crystal violet staining by S. mutans, S. oralis, and S. dentisani in absence or presence of
the cell extract of strain 20J (PCE20J). Experiments were performed in triplicate.
Figure 7. Biofilm formation measured by xCELLigence® (A) and cell growth (B). Measures were done as cell index (biofilm
growth) and OD600 (cell growth) of S. mutans in comparison to control cultures (100%). Different types of extracts from
Tenacibaculum sp. 20J obtained using different solvents such as methanol (MCE), ethylacetate (EA-PCE) and dichlorometane
(DM-MCE20J), and dialyzed PCE and ultracentrifuged PCE were tested as anti-biofilm compounds (n = 3).
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be disregarded that the anti-biofilm activity is enzy-
matic since similar treatments could not neutralize
enzymatic AHL degradation in 20J extracts [36].
In this work, we corroborate previous results that
indicate the suitability of the xCELLigence® system
RTCA to monitor biofilm formation in S. mutans and
other Gram-positive bacteria [25–28]. The
xCELLigence® system constitutes a low time-consum-
ing method for real-time quantification and contin-
uous scrutiny of bacterial cell adhesion, in contrast to
methods based on staining, microscopic visualization,
quantification of biofilm-associated cells in situ, or
after detachment from the substrate, and indirect
methods such as DNA quantification, XTT reduction
assay, or dry cell weight assay which are usually end-
point techniques. The inhibitory effect of 20J extracts
against S. mutans biofilm formation recorded with
the xCELLigence® system was confirmed by micro-
scope observation of crystal violet and fluorescence-
stained biofilms indicating the suitability of this tech-
nology for monitoring bacterial biofilm. However, the
crystal violet quantification method could only detect
differences between 20J extract-treated and untreated
S. mutans cultures when a thick biofilm formation is
promoted by culture medium renewal, being there-
fore less sensitive than the xCELLigence® system.
Furanone C30 at a concentration of 0.02 μg ml−1 had
no effect on biofilm formation by S. mutans as assessed
by the xCELLigence® system. Furanone has been
reported as a QS inhibitor that affects biofilm formation
in S. mutans using the safranine staining and MTT [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide] assays as quantification methods [22,23],
although the active concentrations (0.15–4 μg ml−1)
were significantly higher than those assayed in the pre-
sent study (0.02 μg ml−1) and close to the toxicity
threshold for this molecule that has been established
at concentrations ≥1 µM (0.2 μg ml−1) [44]. He et al.
[23] indicate that the furanone acts through an
unknown mechanism not dependent of the production
of the QS-signal AI-2 since it affected not only S.
mutans but also the luxS mutant strain. In any case,
the toxicity described for these molecules, causing the
rapid death of fish [44], and the development of resis-
tance to furanone-based QS inhibitors [45] exclude the
use of these molecules as antimicrobial agents.
Several reports describe the inhibition of biofilm
formation by S. mutans through the interference with
the AI-2 QS system reducing significantly the biomass,
the average depth, and the maximum depth of the
biofilm [18]. However, the structure of the AI-2 pro-
duced by streptococci is unknown [22], more studies
being needed to understand the interference of 20J
extracts and other inhibitors with the AI-2 QS system
in this species. Although additional experiments using
mixed species models would be required in order to
evaluate the potential of 20J extracts to prevent dental
plaque formation and to control the progress of oral
chronic infections such as periodontitis, the inhibition
of the biofilm formation observed in another two oral
streptococci, S. oralis and S. dentisani, indicates a wide
spectrum activity.
Figure 8. Effect of different treatments on the anti-biofilm activity of the cell extract of strain 20J (100 μg ml−1) against S.
mutans measured by xCELLigence® system (■). (A) Activity of extracts fractionated by molecular weight <100 kDa (□), the <50
kDa (○), and the <10 kDa (◊). (B) Effect of temperature (●) (100°C, 10 min) and treatment with proteinase K (▲)(1 h at 30°C) on
the activity of the PCE. All cultures were carried out in triplicate.
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Recent studies indicate that the QS networks in S.
mutans are complex and should be explored in mixed
biofilms in which other QS signals could be present
[46–48]. The potential use of QQ strategies like 20J
extracts to prevent biofilm formation by S. mutans
and other oral pathogens is an attractive alternative
since these approaches do not interfere with bacterial
growth and hence, the probabilities of inducing resis-
tance or tolerance against these mechanisms are
lower. Also the broad spectrum QQ activity present
in the cell extracts of Tenacibaculum sp. 20J, interfer-
ing with both AI-2 and AHL QS signals, could be
applied to prevent mono and multi-species biofilms.
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